Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-21

FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Xiromed, LLC)

View source ↗

Summary

FDA approved a supplemental application for Xiromed, LLC to support the generic product of norethindrone acetate and ethinyl estradiol tablets with ferrous fuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets (Norethindrone acetate and ethinyl estradiol)

Snippet

SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS)